Werewolf Therapeutics, Inc. 8-K Filing

Ticker: HOWL · Form: 8-K · Filed: Dec 18, 2025 · CIK: 1785530

Werewolf Therapeutics, Inc. 8-K Filing Summary
FieldDetail
CompanyWerewolf Therapeutics, Inc. (HOWL)
Form Type8-K
Filed DateDec 18, 2025
Pages6
Reading Time7 min
Key Dollar Amounts$0.0001
Sentimentneutral

Sentiment: neutral

FAQ

What type of filing is this?

This is a 8-K filing submitted by Werewolf Therapeutics, Inc. (ticker: HOWL) to the SEC on Dec 18, 2025.

What are the key financial figures in this filing?

Key dollar amounts include: $0.0001 (nge on which registered Common Stock, $0.0001 par value per share HOWL The Nasdaq).

How long is this filing?

Werewolf Therapeutics, Inc.'s 8-K filing is 6 pages with approximately 1,704 words. Estimated reading time is 7 minutes.

Where can I view the full 8-K filing?

The complete filing is available on SEC EDGAR. You can also read the AI-decoded analysis with risk assessment and key highlights on ReadTheFiling.

Filing Stats: 1,704 words · 7 min read · ~6 pages · Grade level 15.7 · Accepted 2025-12-18 08:24:44

Key Financial Figures

  • $0.0001 — nge on which registered Common Stock, $0.0001 par value per share HOWL The Nasdaq

Filing Documents

Financial Statements and Exhibits

Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Investor Presentation, dated December 2025 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. WEREWOLF THERAPEUTICS, INC. By: Date: December 18, 2025 /s/ Timothy W. Trost Timothy W. Trost Chief Financial Officer and Treasurer

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.